Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Hematologic Predictors of Outcomes in Patients Undergoing Intensive Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia

Saad Arain, MD, Eshana Shah, MD, Betul Gok Yavuz, MD PhD, Sarah Stettner, Gregory Sampang Calip, PharmD,MPH,PhD, Irum Khan, MD, Pritesh Patel, MB, ChB, John G. Quigley

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-136708

Published: 2020

Journal Articles

High Rates of Varicella Zoster Virus Antibody Seroconversion and Persistence after Administration of the Adjuvanted, Recombinant Varicella Zoster Vaccine in Multiple Myeloma Patients Undergoing Active Treatment

Karen Sweiss, PharmD, Gregory Sampang Calip, PharmD,MPH,PhD, Damiano Rondelli, MD, Pritesh Patel, MB, ChB

Blood (2020) 136 (Supplement 1): 50.

https://doi.org/10.1182/blood-2020-143342

Published: 2020

Journal Articles

Comparison of Individualized Versus MAP-Bayesian Predicted AUC of Busulfan in FluBu4 Treated Patients Undergoing Allogeneic Transplant

Karen Sweiss, PharmD, Eric Wenzler, Hung H Nguyen, MLS, Avadhut D Joshi, PhD, Rosa Yeh, PharmD, Gregory Sampang Calip, PharmD,MPH,PhD, Jeremy Johnson, PharmD, PhD, Donald Irby, PhD, Mitch A. Phelps, PhD, Damiano Rondelli, MD, Pritesh Patel, MB, ChB

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-143430

Published: 2020

Journal Articles

Increased DNA Repair Gene Expression Correlates with MYC Expression and Inferior Progression-Free Survival in Multiple Myeloma Patients

Karen Sweiss, PharmD, Benjamin G Barwick, PhD, Gregory Sampang Calip, PharmD,MPH,PhD, Damiano Rondelli, MD, Craig C Hofmeister, MDMPH, Pritesh Patel, MB, ChB

Blood (2020) 136 (Supplement 1): 48–49.

https://doi.org/10.1182/blood-2020-143422

Published: 2020

Journal Articles

Low Pre-Treatment Hemoglobin and Creatinine Clearance Correlate with Worse Overall Survival, Treatment-Related Mortality, and Regimen-Related Toxicities in Patients Undergoing a Reduced-Intensity Allogeneic Stem Cell Transplantation with Fludarabine and Melphalan

Karen Sweiss, PharmD, Gregory Sampang Calip, PharmD,MPH,PhD, Jeremy Johnson, PharmD, PhD, Jaime Holden, BFA, Paulina Lewkowski, BS, Iryna Mialik, AS, John P Galvin, MDMS,MPH, Damiano Rondelli, MD, Pritesh Patel, MB, ChB

Blood (2019) 134 (Supplement_1): 1980.

https://doi.org/10.1182/blood-2019-131886

Published: 2019

Journal Articles

Monitoring of Stored Hematopoietic Stem/Progenitor Graft Stability Program in a Single Institute

Youngmin Park, MS, Grace Irene, BS, Amudha Ganapathy, PhD, Dolores Mahmud, PhD, Pritesh Patel, MB, ChB, Damiano Rondelli, MD, Nadim Mahmud, MBBS, PhD

Blood (2019) 134 (Supplement_1): 1968.

https://doi.org/10.1182/blood-2019-132145

Published: 2019

Journal Articles

High Rates of Varicella Zoster Virus Antibody Seroconversion after Administration of the Adjuvanted, Recombinant Varicella Zoster Vaccine in Multiple Myeloma Patients Undergoing Active Treatment

Karen Sweiss, PharmD, Gregory Sampang Calip, PharmD,MPH,PhD, John P Galvin, MDMS,MPH, Damiano Rondelli, MD, Pritesh Patel, MB, ChB

Blood (2019) 134 (Supplement_1): 3081.

https://doi.org/10.1182/blood-2019-131914

Published: 2019

Journal Articles

Development of a Real Time Pharmacokinetic Testing Method to Allow for Targeted Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous Transplant

Karen Sweiss, PharmD, Bhaskar Vemu, PhD, Gregory Sampang Calip, PharmD,MPH,PhD, John P Galvin, MDMS,MPH, John G. Quigley, Nadim Mahmud, MBBS, PhD, Damiano Rondelli, MD, Jeremy Johnson, PharmD, PhD, Pritesh Patel, MB, ChB

Blood (2019) 134 (Supplement_1): 3310.

https://doi.org/10.1182/blood-2019-132216

Published: 2019

Journal Articles

A Single Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) for Treatment of Patients with Relapsed or Refractory Acute Myeloid Leukemia

Sonia Christian, MD, Pritesh Patel, MB, CHB, Aysenur Esen, MD, Irum Khan, MBBS, Karen Sweiss, PharmD, Fares Ghanem, MD, Christopher A. Sequeira, MD, Ardaman Shergill, MD, John G. Quigley, MD

Blood (2017) 130 (Supplement 1): 2591.

https://doi.org/10.1182/blood.V130.Suppl_1.2591.2591

Published: 2017

Journal Articles

Combined Immune Score of Lymphocyte to Monocyte Ratio and Immunoglobulin Levels Predicts Progression-Free Survival of Myeloma Patients after Autologous Transplant

Karen Sweiss, PharmD, Jonathan Lee, Annie L. Oh, MD, Gregory Sampang Calip, PharmD,MPH,PhD, Nadim Mahmud, MBBS, PhD, Damiano Rondelli, MD, Pritesh Patel, MB, CHB

Blood (2017) 130 (Supplement 1): 2012.

https://doi.org/10.1182/blood.V130.Suppl_1.2012.2012

Published: 2017

Journal Articles

Acute Kidney Injury before Day 90 Predicts for Both Early and Late Mortality after FluBu4

Karen Sweiss, PharmD, Annie L. Oh, MD, John G. Quigley, MD, Gregory Sampang Calip, PharmD,MPH,PhD, Damiano Rondelli, MD, Pritesh Patel, MB, CHB

Blood (2017) 130 (Supplement 1): 1941.

https://doi.org/10.1182/blood.V130.Suppl_1.1941.1941

Published: 2017

Journal Articles

Similar Survival but Increased Toxicity with a Sequential Versus Concurrent FluBu4 Regimen

Karen Sweiss, PharmD, Annie L. Oh, MD, Gregory Sampang Calip, PharmD,MPH,PhD, John G. Quigley, MD, Damiano Rondelli, MD, Pritesh Patel, MB, CHB

Blood (2017) 130 (Supplement 1): 1942.

https://doi.org/10.1182/blood.V130.Suppl_1.1942.1942

Published: 2017

Journal Articles

Stable Engraftment with Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Sickle Cell Disease

Santosh L. Saraf, MD, Pritesh Patel, MB, CHB, Karen Sweiss, PharmD, Oh Annie, MD, Matthew Koshy, MD, Sally Campbell-lee, MD, Michel Gowhari, DO, Shivi Jain, MD, David Peace, MD, John G. Quigley, MD, Irum Khan, MBBS, Robert E. Molokie, MD, Nadim Mahmud, MBBS, PhD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2017) 130 (Supplement 1): 4591.

https://doi.org/10.1182/blood.V130.Suppl_1.4591.4591

Published: 2017

Journal Articles

Collaborative Physician-Pharmacist Multiple Myeloma Clinic Improves Guideline Adherence and Prevents Treatment Delays

Karen Sweiss, PharmD, Scott Wirth, PharmD, Irene Park, Helen Sweiss, Pritesh Patel, MB, CHB

Blood (2017) 130 (Supplement 1): 2112.

https://doi.org/10.1182/blood.V130.Suppl_1.2112.2112

Published: 2017

Journal Articles

Combined Nanoparticle Delivery of PARP and DNA-PK Inhibition for Multiple Myeloma

Pritesh Patel, MB, CHB, Santosh Misra, PhD, Natalie S. Rodriguez, MS, Gururaja Vulugundam, PhD, Annie L. Oh, MD, Vitalyi Senyuk, PhD, Nadim Mahmud, MBBS, PhD, Damiano Rondelli, MD, Dipanjan Pan

Blood (2017) 130 (Supplement 1): 1809.

https://doi.org/10.1182/blood.V130.Suppl_1.1809.1809

Published: 2017

NARROW

Hematologic Predictors of Outcomes in Patients Undergoing Intensive Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia

High Rates of Varicella Zoster Virus Antibody Seroconversion and Persistence after Administration of the Adjuvanted, Recombinant Varicella Zoster Vaccine in Multiple Myeloma Patients Undergoing Active Treatment

Comparison of Individualized Versus MAP-Bayesian Predicted AUC of Busulfan in FluBu4 Treated Patients Undergoing Allogeneic Transplant

Increased DNA Repair Gene Expression Correlates with MYC Expression and Inferior Progression-Free Survival in Multiple Myeloma Patients

Low Pre-Treatment Hemoglobin and Creatinine Clearance Correlate with Worse Overall Survival, Treatment-Related Mortality, and Regimen-Related Toxicities in Patients Undergoing a Reduced-Intensity Allogeneic Stem Cell Transplantation with Fludarabine and Melphalan

Monitoring of Stored Hematopoietic Stem/Progenitor Graft Stability Program in a Single Institute

High Rates of Varicella Zoster Virus Antibody Seroconversion after Administration of the Adjuvanted, Recombinant Varicella Zoster Vaccine in Multiple Myeloma Patients Undergoing Active Treatment

Development of a Real Time Pharmacokinetic Testing Method to Allow for Targeted Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous Transplant

A Single Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) for Treatment of Patients with Relapsed or Refractory Acute Myeloid Leukemia

Combined Immune Score of Lymphocyte to Monocyte Ratio and Immunoglobulin Levels Predicts Progression-Free Survival of Myeloma Patients after Autologous Transplant

Acute Kidney Injury before Day 90 Predicts for Both Early and Late Mortality after FluBu4

Similar Survival but Increased Toxicity with a Sequential Versus Concurrent FluBu4 Regimen

Stable Engraftment with Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Sickle Cell Disease

Collaborative Physician-Pharmacist Multiple Myeloma Clinic Improves Guideline Adherence and Prevents Treatment Delays

Combined Nanoparticle Delivery of PARP and DNA-PK Inhibition for Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only